FREE Case Review (866) 588-0600

New Jersey Woman Alleges Kidney Failure from Invokana

A woman from New Jersey has filed a lawsuit against Johnson & Johnson and its Janssen subsidiary for failing to warn about the risk of kidney failure from Invokana.

A woman from New Jersey has filed a lawsuit against Johnson & Johnson and its Janssen subsidiary for failing to warn about the risk of kidney failure from the diabetes medication Invokana (generic: canagliflozin).

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by the side effects of Invokana, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

May 1, 2017 – According to the lawsuit (PDF), Plaintiff Jessica Calongne developed an acute kidney injury less than a month after starting treatment with Invokana, which eventually led to kidney failure (end-stage renal disease or “ERSD”).

Calongne alleges that she was prescribed Invokana for the treatment of diabetes in April 2015, and developed ERSD by the end of the next month. She claims J&J misrepresented that Invokana is a safe and effective treatment for diabetes when in fact the medicine can lead to adverse health consequences which require hospitalization, including diabetic ketoacidosis (DKA) and kidney failure.

Invokana was the first of a new class of diabetes drugs known as sodium glucose cotransporter 2 (SGLT-2) inhibitors that work by altering normal kidney functions to increase the amount of sugar excreted in the urine. Other members of this new class include Farxiga, Xigduo XR and Jardiance.

Calongne alleges that her injuries were preventable and the result of J&J’s failure to adequately test Invokana and warn the public and medical community about its potential health risks. Plaintiff also claims the manufacturers withheld information in an effort to maximize profits.

Calongne’s lawsuit will be consolidated as part of multidistrict litigation No. 2750 before U.S. District Judge Brian Martinotti in the District of New Jersey. MDLs are common in pharmaceutical litigation in which multiple lawsuits are filed alleging similar injuries. They are intended to reduce duplicative discovery, avoid conflicting rulings by different judges, and to serve the convenience of both parties.

Do I Have an Invokana Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Case Evaluation: Again, if you were harmed by Invokana side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition